Neuro Alert

What Neuro Alert does

Neuro Alert, doing business as Global Electroneurodiagnostics, is a privately held US company founded in 2007 and headquartered in White Plains, New York. The company operates as a multi-venture entity in the electroneurodiagnostics (END) space, targeting healthcare providers, hospitals, and clinics that require neural mapping, intraoperative neurophysiological monitoring (IONM), and spinal cord stimulation solutions. Its stated mission is to democratize access to neurodiagnostic services globally, citing the statistic that 80% of the world lacks access to END services.

The company offers two primary products. SpineStim NM is a medical device aimed at addressing challenges in spinal cord stimulation therapy, with an emphasis on patient access. Bottlenose AI is an AI-powered IONM solution positioned to make complex neurodiagnostics simpler and more accessible. Underlying both products is a technology stack that combines targeted signal processing, advanced sensor technologies, and AI frameworks applied to neural mapping and protection. The company self-describes four focus areas: Medical Devices, Artificial Intelligence, Education Products, and Research.

Neuro Alert employs 101-250 people and distributes its solutions through a direct partnership and collaboration model targeting enterprise healthcare buyers. Pricing is not publicly disclosed; the website operates on a quote-based, contact-form inquiry model. No funding rounds, named customers, patents, regulatory certifications, or commercial traction metrics are disclosed in the available source data, which constitutes a material information gap for any investment diligence.

Name

Neuro Alert

Legal name

Global Electronurodianostics

Website

https://neuroalert.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

101–250 employees

Short description

Neuro Alert (Global Electroneurodiagnostics) is a US-based medtech company developing electroneurodiagnostic solutions, including the SpineStim NM spinal cord stimulation device and Bottlenose AI IONM platform, serving healthcare providers and medical facilities globally.

Ownership category

akta.pro rank

Product category

Neurodiagnostic Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Implantable Neuromodulation & Neurostimulation (SCS/DBS/VNS/PNS) (HLAHAEAK)

akta.pro secondary industry

Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)

Keywords

• Neurodiagnostic technology
• Intraoperative neuromonitoring
• Spinal cord stimulation devices
• Neural mapping systems
• Electroneurodiagnostic solutions

Headquarters

HQ city

White Plains

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Distribution channels1 record

Marketing channels2 records

Core offering

Neuro Alert (Global Electroneurodiagnostics) develops and delivers electroneurodiagnostic (END) technology solutions for healthcare providers, anchored by two ventures: SpineStim NM, a medical device addressing spinal cord stimulation therapy, and Bottlenose AI, an AI-powered intraoperative neurophysiological monitoring (IONM) platform. Products leverage targeted signal processing, sensor technologies, and AI frameworks to make advanced neural mapping and protection more accessible and affordable globally.

Product overview

Neuro Alert (Global Electroneurodiagnostics) operates as a multi-venture company focused on electroneurodiagnostic technology. The company offers two main products: SpineStim NM, a medical device addressing spinal cord stimulation therapy challenges, and Bottlenose AI, an AI-powered intraoperative neurophysiological monitoring (IONM) solution. Both products are designed to improve patient access to affordable neurodiagnostic services globally, leveraging advanced signal processing, sensor technologies, and AI frameworks.

Differentiator

Problem solved

Functional benefit

Brands

• SpineStim NM: A solution to spinal cord stimulation therapy challenges, focused on patient access and care.
• Bottlenose AI

Products and services

• SpineStim NM Spinal cord stimulation therapy medical device designed to address challenges in spinal cord stimulation treatment, emphasizing patient access, care quality, and innovation for healthcare providers and patients.
• Bottlenose AI Scalable AI-powered intraoperative neurophysiological monitoring (IONM) solution that brings advanced neurodiagnostics to healthcare settings, making complex neurodiagnostics simpler and more accessible for clinicians and surgical teams.

Quantifiable outcome

• SpineStim NM addresses spinal cord stimulation therapy challenges to improve patient access
• +1 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Cadwell Industries: Cadwell manufactures IONM and neurodiagnostic equipment (EEG, EMG, IONM) used by hospitals and surgical teams. Like Neuro Alert, it sells into the same surgical neurophysiology end-market, making it a direct channel and product competitor for Bottlenose AI.
• Natus Medical: Natus is one of the largest dedicated neurodiagnostics and IONM platform providers (acquired by Nihon Kohden-adjacent consortium). It directly overlaps with Neuro Alert's Bottlenose AI offering in intraoperative neurophysiological monitoring hardware, software, and consumables, serving the same hospital neurology and surgical monitoring end-customers.

Broad incumbents

• Medtronic: Medtronic is a global leader in implantable spinal cord stimulation (PainStim, Vanta, Intellis) and DBS systems, competing head-on with Neuro Alert's SpineStim NM. It also operates in broader neuromodulation across multiple indications, giving it scale, clinical evidence, and reimbursement infrastructure Neuro Alert lacks.
• Boston Scientific: Boston Scientific's Neuromodulation division (Precision Spectra, WaveWriter SCS) is a major competitor to SpineStim NM in spinal cord stimulation. It is a broader incumbent with established sales channels into pain and spine practices that Neuro Alert would need to displace.
• Abbott (St. Jude Medical / Neuromodulation): Abbott Neuromodulation (Proclaim XR, Prodigy, Eterna) competes in the same SCS implant market as SpineStim NM and has a global sales force and clinical-trial infrastructure. It represents the largest pool of incumbent share a Neuro Alert SCS entry would need to address.
• Nihon Kohden: Nihon Kohden is a global leader in EEG, EMG, and IONM systems, and acquired Natus Neuro. It is comparable to Neuro Alert on the IONM/neurodiagnostic hardware and software side and benefits from a much larger installed base and international distribution.

Emerging players

• Brainlab: Brainlab provides surgical visualization, planning, and AI-augmented intraoperative software that overlaps with Bottlenose AI's IONM/AI mission in the operating room. It is comparable as a software/AI-led surgical technology peer advancing workflow intelligence in neurosurgery and spine.
• Moberg Analytics: Moberg Analytics (formerly Moberg Research) provides ICU and continuous bedside neuro-monitoring solutions (e.g., Continuous EEG, CNS Monitor). It overlaps with Neuro Alert's Bottlenose AI in AI-driven neurophysiology monitoring for critically ill and surgical patients.
• WAVE Neuroscience: WAVE Neuroscience (MyndMove, BurstDR-like and other stimulation technologies) is a neuromodulation company working on spinal cord and brain stimulation applications, comparable to Neuro Alert's SpineStim NM. It represents an emerging player attempting to displace legacy SCS systems with novel waveform and indication strategies.

Others

• SpecialtyCare: SpecialtyCare is one of the largest providers of intraoperative neurophysiological monitoring services (technologists and oversight), competing with Neuro Alert on the service-delivery side of IONM. It is a useful comparable because hospitals increasingly decide between outsourced IONM service and in-house technology like Bottlenose AI.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• Instagraminstagram.com/globalelectroneurodiagnostics
• LinkedInlinkedin.com/company/globalelectroneurodiagnostics
• Xx.com/neuroalert
• Facebookfacebook.com/globalelectroneurodiagnostics

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Neuro Alert